SLGL
Sol-Gel Technologies Ltd.
Price Chart
Latest Quote
$74.46
+2.46 (+3.42%)
Current Price
| Previous Close | $72.00 |
| Open | $71.57 |
| Day High | $74.46 |
| Day Low | $69.54 |
| Volume | 17,522 |
Stock Information
| Shares Outstanding | 3.27M |
| Total Debt | $862K |
| Cash Equivalents | $52.83M |
| Revenue | $18.46M |
| Net Income | $-1.05M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $243.41M |
| EPS (TTM) | $-0.30 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $186.25M |
| Sales | $18.46M |
| Income | $-1.05M |
| Book/sh | $15.72 |
| Cash/sh | $16.16 |
| Employees | 28 |
Financial Ratios
| Quick Ratio | 8.54 |
| Current Ratio | 8.84 |
| Debt/Eq | 1.68 |
Returns & Margins
| ROA | -3.47% |
| ROE | -2.92% |
| Gross Margin | 9.30% |
| Operating Margin | -3569.44% |
| Profit Margin | -5.66% |
Ownership
| Insider Ownership | 59.70% |
| Institutional Ownership | 41.75% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -6.84 |
| P/S | 13.18 |
| P/B | 4.74 |
Analyst Data
| Recommendation | none |
| Target Price | $147.00 |
Technical Indicators
| SMA20 | $74.02 |
| SMA50 | $73.09 |
| SMA200 | $57.24 |
| RSI | 50.84 |
| ATR | 5.4260 |
| Shares Float | 534K |
| Short Float | 5.04% |
| Short Ratio | 1.84 |
| Volatility | 1.13 |
| Rel Volume | 0.40 |
Performance History
| Week | -1.12% |
| Month | +17.61% |
| Quarter | -8.87% |
| 6 Months | +76.76% |
| YTD | +76.65% |
| Year | +963.11% |
| 3 Years | +120.30% |
| 5 Years | -33.93% |
| 10 Years | -45.41% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $74.46 | 17,600 |
| 2026-06-17 | $70.36 | 26,100 |
| 2026-06-16 | $72.87 | 50,900 |
| 2026-06-15 | $73.82 | 33,900 |
| 2026-06-12 | $73.44 | 44,700 |
| 2026-06-11 | $75.30 | 45,000 |
| 2026-06-10 | $73.50 | 21,500 |
| 2026-06-09 | $76.22 | 42,600 |
| 2026-06-08 | $80.00 | 59,500 |
| 2026-06-05 | $77.98 | 23,700 |
| 2026-06-04 | $74.37 | 69,000 |
| 2026-06-03 | $71.50 | 27,000 |
| 2026-06-02 | $73.73 | 13,100 |
| 2026-06-01 | $70.40 | 40,000 |
| 2026-05-29 | $73.86 | 38,900 |
| 2026-05-28 | $75.28 | 77,800 |
| 2026-05-27 | $73.80 | 29,100 |
| 2026-05-26 | $74.50 | 80,000 |
| 2026-05-22 | $76.73 | 76,800 |
| 2026-05-21 | $68.31 | 63,600 |
| 2026-05-20 | $65.29 | 21,600 |
| 2026-05-19 | $63.31 | 12,500 |
About Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
đ° Latest News
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-28T13:10:02Z
US Equity Indexes Fall Amid Uncertainty Over US-Iran Truce Talks
MT Newswires âĸ 2026-03-24T20:48:38ZSol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
Zacks âĸ 2026-03-19T18:00:01Z
Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 940% return over the last year
Simply Wall St. âĸ 2026-02-11T18:23:38Z
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth
Simply Wall St. âĸ 2025-12-29T12:41:00Z
Insiders At Sol-Gel Technologies See Good Returns After Buying Stock Worth US$867.1k
Simply Wall St. âĸ 2025-11-10T13:28:15Z
Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 240% return over the last year
Simply Wall St. âĸ 2025-09-04T18:20:01Z
We're Keeping An Eye On Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate
Simply Wall St. âĸ 2025-07-22T11:52:04Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $19,388,000 | $11,538,000 | $1,554,000 | $3,883,000 |
| Operating Revenue | $19,388,000 | $11,538,000 | $1,554,000 | $3,883,000 |
| Expenses | ||||
| Total Expenses | $26,926,000 | $23,552,000 | $30,859,000 | $20,127,000 |
| Net Non Operating Interest Income Expense | $1,411,000 | $1,434,000 | $2,067,000 | $1,321,000 |
| Operating Expense | $26,926,000 | $23,552,000 | $30,859,000 | $20,127,000 |
| Other Operating Expenses | $-54,000 | - | $-55,000 | - |
| General And Administrative Expense | $4,176,000 | $5,749,000 | $7,373,000 | $7,445,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Net Interest Income | $1,411,000 | $1,434,000 | $2,067,000 | $1,321,000 |
| Interest Income | $1,411,000 | $1,434,000 | $2,067,000 | $1,321,000 |
| Normalized Income | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Net Income From Continuing And Discontinued Operation | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Total Operating Income As Reported | $-7,538,000 | $-12,014,000 | $-29,305,000 | $-16,244,000 |
| Net Income Common Stockholders | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Net Income | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Net Income Including Noncontrolling Interests | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Net Income Continuous Operations | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Pretax Income | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Interest Income Non Operating | $1,411,000 | $1,434,000 | $2,067,000 | $1,321,000 |
| Operating Income | $-7,538,000 | $-12,014,000 | $-29,305,000 | $-16,244,000 |
| Per Share | ||||
| Diluted EPS | $-2.19 | $-3.79 | $-10.01 | $-6.50 |
| Basic EPS | $-2.19 | $-3.79 | $-10.01 | $-6.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,429,000 | $-11,781,000 | $-28,963,000 | $-15,682,000 |
| Reconciled Depreciation | $109,000 | $233,000 | $342,000 | $562,000 |
| EBITDA (Bullshit earnings) | $-7,429,000 | $-11,781,000 | $-28,963,000 | $-15,682,000 |
| EBIT | $-7,538,000 | $-12,014,000 | $-29,305,000 | $-16,244,000 |
| Diluted Average Shares | $2,785,875 | $2,785,787 | $2,708,708 | $2,312,872 |
| Basic Average Shares | $2,785,875 | $2,785,787 | $2,708,708 | $2,312,872 |
| Diluted NI Availto Com Stockholders | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Research And Development | $22,804,000 | $17,803,000 | $23,541,000 | $12,682,000 |
| Selling General And Administration | $4,176,000 | $5,749,000 | $7,373,000 | $7,445,000 |
| Other Gand A | $4,176,000 | $5,749,000 | $7,373,000 | $7,445,000 |
| Tax Provision | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $22,811,000 | $28,850,000 | $38,644,000 | $42,213,000 |
| Total Assets | $29,917,000 | $35,846,000 | $45,287,000 | $46,628,000 |
| Total Non Current Assets | $2,946,000 | $4,551,000 | $4,120,000 | $3,573,000 |
| Other Non Current Assets | $1,386,000 | $1,304,000 | $1,339,000 | $1,288,000 |
| Current Assets | $26,971,000 | $31,295,000 | $41,167,000 | $43,055,000 |
| Other Current Assets | $1,004,000 | $3,774,000 | $2,794,000 | $1,509,000 |
| Receivables | $1,968,000 | $3,595,000 | $377,000 | $7,920,000 |
| Accounts Receivable | $1,968,000 | $3,595,000 | $377,000 | $62,000 |
| Cash Cash Equivalents And Short Term Investments | $23,999,000 | $23,926,000 | $37,996,000 | $33,626,000 |
| Cash And Cash Equivalents | $11,033,000 | $19,489,000 | $7,513,000 | $12,448,000 |
| Non Current Accounts Receivable | - | $1,024,000 | - | - |
| Other Receivables | - | - | - | $7,858,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $991,000 | $1,308,000 | $1,653,000 | $772,000 |
| Long Term Debt And Capital Lease Obligation | $496,000 | $878,000 | $1,206,000 | $54,000 |
| Current Debt And Capital Lease Obligation | $495,000 | $430,000 | $447,000 | $718,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,106,000 | $6,996,000 | $6,643,000 | $4,415,000 |
| Total Non Current Liabilities Net Minority Interest | $935,000 | $1,711,000 | $2,121,000 | $1,086,000 |
| Current Liabilities | $6,171,000 | $5,285,000 | $4,522,000 | $3,329,000 |
| Payables And Accrued Expenses | $5,676,000 | $4,855,000 | $4,075,000 | $2,611,000 |
| Payables | $2,765,000 | $3,794,000 | $2,021,000 | $1,354,000 |
| Other Payable | $2,030,000 | $2,529,000 | $1,867,000 | $1,103,000 |
| Accounts Payable | $735,000 | $1,265,000 | $154,000 | $251,000 |
| Equity | ||||
| Common Stock Equity | $22,811,000 | $28,850,000 | $38,644,000 | $42,213,000 |
| Total Equity Gross Minority Interest | $22,811,000 | $28,850,000 | $38,644,000 | $42,213,000 |
| Stockholders Equity | $22,811,000 | $28,850,000 | $38,644,000 | $42,213,000 |
| Retained Earnings | $-237,010,000 | $-230,883,000 | $-220,303,000 | $-193,065,000 |
| Other | ||||
| Ordinary Shares Number | $2,786,158 | $2,785,762 | $2,785,762 | $2,312,946 |
| Share Issued | $2,786,158 | $2,785,762 | $2,785,762 | $2,312,946 |
| Tangible Book Value | $22,811,000 | $28,850,000 | $38,644,000 | $42,213,000 |
| Invested Capital | $22,811,000 | $28,850,000 | $38,644,000 | $42,213,000 |
| Working Capital | $20,800,000 | $26,010,000 | $36,645,000 | $39,726,000 |
| Capital Lease Obligations | $991,000 | $1,308,000 | $1,653,000 | $772,000 |
| Total Capitalization | $22,811,000 | $28,850,000 | $38,644,000 | $42,213,000 |
| Additional Paid In Capital | $259,047,000 | $258,959,000 | $258,173,000 | $234,640,000 |
| Capital Stock | $774,000 | $774,000 | $774,000 | $638,000 |
| Common Stock | $774,000 | $774,000 | $774,000 | $638,000 |
| Employee Benefits | $439,000 | $833,000 | $915,000 | $1,032,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $439,000 | $833,000 | $915,000 | $1,032,000 |
| Long Term Capital Lease Obligation | $496,000 | $878,000 | $1,206,000 | $54,000 |
| Current Capital Lease Obligation | $495,000 | $430,000 | $447,000 | $718,000 |
| Current Accrued Expenses | $2,911,000 | $1,061,000 | $2,054,000 | $1,257,000 |
| Defined Pension Benefit | $393,000 | $595,000 | $626,000 | $749,000 |
| Net PPE | $1,167,000 | $1,628,000 | $2,155,000 | $1,536,000 |
| Accumulated Depreciation | $-4,273,000 | $-6,024,000 | $-5,804,000 | $-5,714,000 |
| Gross PPE | $5,440,000 | $7,652,000 | $7,959,000 | $7,250,000 |
| Leases | $467,000 | $1,982,000 | $1,985,000 | $1,993,000 |
| Other Properties | $4,225,000 | $4,930,000 | $5,235,000 | $4,564,000 |
| Machinery Furniture Equipment | $748,000 | $740,000 | $739,000 | $693,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $12,966,000 | $4,437,000 | $30,483,000 | $21,178,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $275,000 | $-13,891,000 | $-17,864,000 | $-9,655,000 |
| Operating Activities | ||||
| Operating Cash Flow | $322,000 | $-13,889,000 | $-17,730,000 | $-9,484,000 |
| Cash Flow From Continuing Operating Activities | $322,000 | $-13,889,000 | $-17,730,000 | $-9,484,000 |
| Operating Gains Losses | $-246,000 | $-55,000 | $-49,000 | $20,000 |
| Investing Activities | ||||
| Capital Expenditure | $-47,000 | $-2,000 | $-134,000 | $-171,000 |
| Investing Cash Flow | $-8,580,000 | $26,692,000 | $-9,742,000 | $1,699,000 |
| Cash Flow From Continuing Investing Activities | $-8,580,000 | $26,692,000 | $-9,742,000 | $1,699,000 |
| Net Other Investing Changes | - | - | - | $10,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $21,542,000 | $0 |
| Financing Cash Flow | $6,000 | $0 | $21,810,000 | $15,000 |
| Cash Flow From Continuing Financing Activities | $6,000 | $0 | $21,810,000 | $15,000 |
| Net Common Stock Issuance | $0 | $0 | $21,542,000 | $0 |
| Common Stock Issuance | $0 | $0 | $21,542,000 | $0 |
| Other | ||||
| End Cash Position | $12,225,000 | $20,665,000 | $7,863,000 | $13,598,000 |
| Beginning Cash Position | $20,665,000 | $7,863,000 | $13,598,000 | $21,235,000 |
| Effect Of Exchange Rate Changes | $-188,000 | $-1,000 | $-73,000 | $133,000 |
| Changes In Cash | $-8,252,000 | $12,803,000 | $-5,662,000 | $-7,770,000 |
| Proceeds From Stock Option Exercised | $6,000 | $0 | $268,000 | $15,000 |
| Net Investment Purchase And Sale | $-8,587,000 | $26,688,000 | $-9,682,000 | $1,870,000 |
| Sale Of Investment | $5,523,000 | $26,688,000 | $14,295,000 | $11,876,000 |
| Purchase Of Investment | $-14,110,000 | $0 | $-23,977,000 | $-10,006,000 |
| Net PPE Purchase And Sale | $7,000 | $4,000 | $-60,000 | $-171,000 |
| Sale Of PPE | $54,000 | $6,000 | $74,000 | $0 |
| Purchase Of PPE | $-47,000 | $-2,000 | $-134,000 | $-171,000 |
| Change In Working Capital | $6,192,000 | $-4,402,000 | $7,668,000 | $3,538,000 |
| Change In Payables And Accrued Expense | $820,000 | $780,000 | $1,465,000 | $-8,300,000 |
| Change In Payable | $820,000 | $780,000 | $1,465,000 | $-8,300,000 |
| Change In Account Payable | $820,000 | $780,000 | $1,465,000 | $-8,300,000 |
| Change In Prepaid Assets | $2,770,000 | $-981,000 | $-1,340,000 | $-709,000 |
| Change In Receivables | $2,602,000 | $-4,201,000 | $7,543,000 | $12,547,000 |
| Changes In Account Receivables | $1,626,000 | $-3,218,000 | $7,543,000 | $12,547,000 |
| Other Non Cash Items | $286,000 | $-46,000 | $124,000 | $-327,000 |
| Stock Based Compensation | $82,000 | $786,000 | $1,859,000 | $1,527,000 |
| Unrealized Gain Loss On Investment Securities | $26,000 | $175,000 | $-436,000 | $119,000 |
| Depreciation Amortization Depletion | $109,000 | $233,000 | $342,000 | $562,000 |
| Depreciation And Amortization | $109,000 | $233,000 | $342,000 | $562,000 |
| Depreciation | $109,000 | $233,000 | $342,000 | $562,000 |
| Pension And Employee Benefit Expense | $-192,000 | $-51,000 | $6,000 | $20,000 |
| Gain Loss On Sale Of PPE | $-54,000 | $-4,000 | $-55,000 | $0 |
| Net Income From Continuing Operations | $-6,127,000 | $-10,580,000 | $-27,238,000 | $-14,923,000 |
| Income Tax Paid Supplemental Data | - | - | $0 | $0 |
| Change In Other Working Capital | - | - | - | $-174,000 |
Fetched: 2026-06-18